Mark A Meltz, SVP & GC at Audentes Therapeutics, holds 0.00 shares in Kinnate Biopharma (Ticker: KNTE), holds 0.00 shares in Audentes Therapeutics (Ticker: ~BOLD).
What is the percentage of profitable transactions made by Mark A Meltz?
The percentage of profitable transactions made by Mark A Meltz is ―.
What is the average return per transaction made by Mark A Meltz?
The average return per transaction made by Mark A Meltz is ―.
What stocks does Mark A Meltz hold?
Mark A Meltz holds: ~BOLD, KNTE stocks.
What was Mark A Meltz’s latest transaction?
Mark A Meltz latest transaction was an Uninformative Sell of ―.
What was Mark A Meltz's most profitable transaction?
Mark A Meltz’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Mark A Meltz's role in Audentes Therapeutics?
Mark A Meltz's role in Audentes Therapeutics is SVP & GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.